Background
bullous disorder, pemphigoid
BULLOUS DISORDER, PEMPHIGOID
Edited by: Vinay Keshavamurthy, Post Graduate Institute of Medical Education and Research (PGIMER), IndiaReviewed by: Yuval Tal, Hadassah Medical Center, Israel; Daisuke Tsuruta, Osaka City University, JapanBullous pemphigoid (BP) is a common subepidermal bullous disorder that lacks adequate treatment alternatives. Dupilumab, an anti-interleukin (IL) 4 receptor α antibody blocking Th2 molecules IL-4 and 13, has been used off-label and shown to be effective in refractory BP cases.